This is the third episode of the Prognosis: Misconception podcast series.
Listen to the first episode here, and subscribe on Apple,
Spotify or wherever you get your podcasts.
Fertility is big business in the US. Venture capital and private equity poured into the space in the last five years. It hit a fever pitch in 2023, a record year for such VC deals, with $874 million in investments in fertility startups, according to Pitchbook.
But the boom comes with a downside: pressure to maximize earnings. When the patient is also the profit center, incentives can change. And it’s not just money. The surge ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.